Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
ADM5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
MIR1908 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
FASTKD2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
H2BFXP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
BEAN1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FMOD - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PXYLP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TTTY13 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GDF11 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
POMT2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TRPM7 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
VAC14 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PRKAA2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SMU1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
VCX2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TPGS2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CAMK2D - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on